Circassia Pharmaceuticals plc announced the appointment of Marvin S Samson as a Non-Executive Director. The company also announced that Paul R Edick has informed the Company he will retire from the Board at its meeting on May 17, 2016, and therefore will not seek re-election as a Non-Executive Director at the company's 2016 annual general meeting. Marvin S Samson brings to company 50 years' experience of the specialty pharmaceutical industry, having established and led a number of successful companies.  He is currently Founder and CEO of Samson Medical Technologies LLC, and was until recently Interim President of the University of the Sciences, Philadelphia.  Previously, he was CEO and Chairman of Qualitest Pharmaceuticals, Group Vice President of Injectables at Teva, CEO and President of SICOR, Founder, President and CEO of Marsam Pharmaceuticals and Founder, CEO and President of Elkins-Sinn.  He is currently a Non-Executive Director of Antares Pharma Inc, Flynn Pharma Ltd. and NanoPass Technologies Ltd.  He is also Chairman of the Board of Trustees of the University of the Sciences in Philadelphia and a Board Member of the Cooper Rowan Medical School, Virtua Health and the Franklin Institute.